Home

A recent judgment of the US courts has held that so-called reverse payment settlements entered into by pharmaceutical patent holders with would-be generic entrants are not anti-competitive.  The EU competition authorities could learn from this approach.

By Sophie Lawrance, Bristows LLP

After five years of litigation between the parties, the Court of Justice of the European Union (CJEU) has now handed down its ruling on liability for browsing and caching in Case C-360/13 Public Relations Consultants Association Limited v Newspaper Licensing Agency Limited and Ors.

By Sheena Sheikh Brown, Field Fisher Waterhouse

The Law is no stranger to producing “David v Goliath” scenarios, in which large multinational companies assert their rights against commercial minnows in actions that are often portrayed in the media as a disproportionate, unnecessary or unfair abuse of financial strength and legal might.

By Jason Chester, Marks & Clerk

It remains the great unknown: to what extent does IP contribute to the success or failure of a company (or even an entire industry)? In truth, the possible answer to the question will depend upon the circumstances—pharma will certainly yield a different analysis to that of a media company

By Neil Wilkof

Copyright

Slep-Tone makes karaoke accompaniment tracks sold under the trademark “SOUND CHOICE.” It also alleged a distinctive and protectable trade dress, which includes (a) the use of a particular typeface, style, and visual arrangement in displaying lyrics;

By Rebecca Tushnet

By: Justin McNaughton Google has a fascinating report called the Transparency Report, where it provides statistics on the number of Copyright takedown notices it receives monthly. 8,000,000 a week is incredible. What is more incredible is the speed with which Google typically responds to take down infringing URLs.

By Guest Blogger , Stites & Harbison